TG Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of TG Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-04 | $0.02 | $0.03 | -33.3 % |
Q2 | 2024-08-06 | $0.04 | $-0.05 | 180.0 % |
Q1 | 2024-05-01 | $-0.07 | $-0.04 | -75.0 % |
Q4 | 2024-02-28 | $-0.09 | $-0.10 | 10.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-04 | $83.88M | $81.71M | 2.65 % |
Q2 | 2024-08-06 | $73.47M | $65.89M | 11.5 % |
Q1 | 2024-05-01 | $63.47M | $54.58M | 16.3 % |
Q4 | 2024-02-28 | $43.97M | $40.06M | 9.76 % |
TG Therapeutics (TGTX) is scheduled to report earnings on February 26, 2025. The last reported earnings were for reported on November 4, 2024 for Q3.
The Actual EPS was $0.02, which missed the estimate of $0.03.
The Actual Revenue was $83.9M, which beat the estimate of $81.7M.
Browse earnings estimates, EPS, and revenue on all stocks.